CLevel Interviews Confirm Allogene (ALLO) Best Positioned Among Next Gen Cell Therapies - Piper Jaffray

Go back to CLevel Interviews Confirm Allogene (ALLO) Best Positioned Among Next Gen Cell Therapies - Piper Jaffray
(NASDAQ: ALLO) Delayed: 2.02 +0.04 (2.02%)
Previous Close $1.98    52 Week High
Open $1.96    52 Week Low
Day High $2.04    P/E N/A 
Day Low $1.92    EPS
Volume 2,591,962